Atlas Trials

Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART

Clinical trial NCT01680094 · COMPLETED

Trial details

NCT number
NCT01680094
Sponsor
University of Aarhus
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
HIV Infection
Start date
2012-09-01
Primary completion
2013-09-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.